Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

This study has been terminated.
(Adverse Events)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01238965
First received: November 3, 2010
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)